Ignite Creation Date:
2024-05-06 @ 2:28 PM
Last Modification Date:
2024-10-26 @ 1:31 PM
Study NCT ID:
NCT04322149
Status:
COMPLETED
Last Update Posted:
2023-06-28
First Post:
2020-03-20
Brief Title:
Multiple Doses of AT-1501-A201 in Adults With ALS
Sponsor:
Anelixis Therapeutics LLC
Organization:
Eledon Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-16
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-03-24
Completion Date Type:
ACTUAL
First Submit Date:
2020-03-20
First Submit QC Date:
March 24 2020
Study First Post Date:
2020-03-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-06-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-06
Last Update Post Date:
2023-06-28
Last Update Post Date Type:
ACTUAL